Fuller & Thaler Asset Management
EW icon

Fuller & Thaler Asset Management’s Edwards Lifesciences EW Stock Holding History

Fuller & Thaler Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,500
Closed -$141K – 713
2016
Q4 		$141K Hold
4,500
– – ﹤0.01% 445
2016
Q3 		$181K Buy
4,500
+2,100
+88% +$79.1K ﹤0.01% 347
2016
Q2 		$80K Hold
2,400
– – ﹤0.01% 514
2016
Q1 		$71K Buy
+2,400
New +$66.2K ﹤0.01% 475
2015
Q3 		– Sell
-11,400
Closed -$271K – 689
2015
Q2 		$271K Sell
11,400
-6,000
-34% -$135K 0.01% 369
2015
Q1 		$413K Sell
17,400
-12,000
-41% -$269K 0.01% 331
2014
Q4 		$624K Buy
29,400
+3,000
+11% +$60.3K 0.02% 293
2014
Q3 		$449K Buy
+26,400
New +$417K 0.02% 334

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fuller & Thaler Asset Management's EW Position: Q1 2017 in Review

Fuller & Thaler Asset Management sold out of Edwards Lifesciences (EW) in Q1 2017, closing a stake of 4,500 shares — an estimated $141K sold.

Fuller & Thaler Asset Management first reported a position in EW in Q3 2014 and held it in 8 quarters. The position peaked at $624K in Q4 2014. 691 funds tracked by Wall St. Rank hold EW as of Q1 2017.

  • Fuller & Thaler Asset Management reported no remaining Edwards Lifesciences position as of Q1 2017 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 4,500 Edwards Lifesciences shares in Q1 2017, an estimated $141K.
  • Fuller & Thaler Asset Management first reported a position in Edwards Lifesciences in Q3 2014 and held it in 8 quarters.
  • Fuller & Thaler Asset Management's Edwards Lifesciences position peaked at $624K in Q4 2014.
  • 691 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2017.

Based on Fuller & Thaler Asset Management's 13F filing for Q1 2017, filed 15 May 2017.